Premium
An open‐label cluster‐randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID‐19 (ARCHAIC)—Protocol publication
Author(s) -
Weehuizen Jesper M.,
Hoepelman Andy I. M.
Publication year - 2020
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/eci.13297
Subject(s) - hydroxychloroquine , medicine , chloroquine , tolerability , viral load , population , clinical trial , pharmacology , guideline , antiviral drug , randomized controlled trial , drug , intensive care medicine , covid-19 , adverse effect , virus , immunology , disease , infectious disease (medical specialty) , malaria , pathology , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom